Drug Discovery Pipeline
Highly Valuable Markets

C4X Discovery is using its unique proprietary technologies to build a pipeline of high quality small molecule drug candidates addressing valuable markets with high unmet medical need.

pipeline Apr18

C4XD’s proprietary drug asset portfolio of nine programmes across a number of therapeutic areas including inflammation, neurodegeneration, immuno-oncology, addiction, and diabetes has progressed towards revenue generation. Following the out-licensing of C4XD’s IND-ready Orexin-1 programme to Indivior, the Company now has three lead drug discovery programmes showing in vivo activity, opening up a path to candidate selection and opportunity to progress to partnering discussions.